Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Intriguing Social Unesco World Legacy Locales All over The Planet - 2Intriguing Strange Cruising Objections you Should Visit
- 3What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- 4Israeli archaeologists launch project to trace origins of ancient pottery
- 5Family Holiday spots
- A Manual for the Right SUV for Seniors
- 5 Home Improvement Styles: Decision in favor of Your #1
- Extremely Rare Snub-Nosed Monkey Was Just Born for the First Time Outside of Asia
- Exploring the Difficulties of Beginning a Family: Individual Experiences
- Toyota’s Next Big Sports Car Might Apparently Be a Turbocharged All-Paw Beast
- What to expect from the planets in 2026 — key dates and sky events
- Dominating the Art of Composing: Creator Bits of knowledge
- Improving as a Pioneer: Examples from My Vocation
- Astronomers now say the moon is eating up molecules from Earth’s atmosphere
